Project Grant R01CA303859
Award Date 8/1/25
Completion Date 5/31/30
Dollars Obligated $513K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
- This $300,000 Project Grant awarded by the National Science Foundation (NSF) under the Integrative Activities (CFDA 47.083) program supports the development of an innovative, intelligent surgical probe for prostate cancer treatment. The project aims to create an edge artificial intelligence (AI) system-on-chip for bioimpedance analysis that can accurately distinguish cancerous from healthy tissue during prostate removal surgery. The novel technology being developed includes an adaptive filter to...
- The National Science Foundation awarded $256,000 to Optave Diagnostics LLC through the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a prototype endoscopic probe for molecular imaging and diagnosis of cancerous prostate pathologies. The 12-month project grant will support the creation of a medical device using photoacoustic imaging and acoustic lens technology to aid in the detection and diagnosis of prostate cancer. The proposed endoscopic probe offers an alternative...
- This $681,215 federal Project Grant was awarded on September 1, 2025 by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to New York University (NYU) to develop AI-powered diagnostic tools for early prostate cancer detection. The project aims to leverage machine learning models to infer the presence of clinically significant prostate cancer using a minimal amount of degraded MRI data, in order to enable widespread, cost-effective population-level disease...
- This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $399,995 to Omnecoil Instruments, Inc. to conduct feasibility testing of a novel system for integrated endorectal MRI and in-bore biopsy of the prostate. The goal is to develop a faster, more efficient, and more accurate diagnostic test for the estimated 1.4 million men who develop prostate cancer each year. The study will recruit 30 men...
- The University of Michigan has been awarded a $568,151 Project Grant from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to develop a real-time functional imaging platform for accurate diagnosis and prognosis of prostate cancer. The project aims to leverage photoacoustic imaging and biocompatible hydrogel nanoparticle probes to quantitatively assess prostate gland microarchitecture and tumor microenvironment as imaging biomarkers for improved prostate...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Bullseye Biodevices, Inc. aims to develop a novel biosensing device for rapidly mapping volumetric tumor margins during surgical interventions for cancer. The key product under development is an electromechanical probe and sensor system that can generate real-time, 3D maps of tumor location and boundaries by measuring biophysical properties like force, deformation, and...
- This $1,406,799 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research to develop real-time localization techniques using near-infrared fluorophores to guide robotic-assisted radical prostatectomy procedures. The 3-year award, running from August 1, 2024 to July 31, 2027, will enable Johns Hopkins to conduct innovative biomedical research to improve surgical outcomes and...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $390,916 Project Grant on Jan 15, 2025 to The Johns Hopkins University under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant funds research to optimize polymeric Chemical Exchange Saturation Transfer (CEST) Magnetic Resonance Imaging (MRI) agents for improved sensitivity and specificity in detecting prostate cancer. The key objectives are...
- This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $161,000 to the University of California, Davis to create a prototype surgical probe specifically designed for use with Positron Emission Tomography (PET) radiotracers during laparoscopic prostate cancer resection procedures. The key innovation is the use of two...
- This $354,066 federal Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) will support the development of a smart and connected robotic system for comprehensive diagnosis of abnormal tissues in the abdominal cavity. The award will fund research across three main thrusts: 1) integrating a multimodal instrument with balloon-based ultrasound and Raman spectroscopy capabilities to detect, classify, and stage tissue; 2) developing a tendon-driven continuum...